Diana Álvarez Muñoz, Albert Serra Compte, Natàlia Corcoll, Belinda Huerta, Sara Rodríguez Mozaz, Sergi Sabater, Damià Barceló.

Similar documents
Supporting information

The use of mass spectrometry in lipidomics. Outlines

Mass Spectrometry Infrastructure

Determination of β2-agonists in Pork Using Agilent SampliQ SCX Solid-Phase Extraction Cartridges and Liquid Chromatography-Tandem Mass Spectrometry

Application Note. Author. Abstract. Introduction. Food Safety

Inhibitory Effect of Methotrexate on Rheumatoid Arthritis Inflammation and Comprehensive Metabolomics Analysis Using UPLC-Q/TOF-MS

Chemical Analysis Business Operations Waters Corporation Milford MA

Simple and Robust Measurement of Blood Plasma Lysophospholipids Using Liquid Chromatography Mass Spectrometry

Quantitative Analysis of Drugs of Abuse in Urine using UHPLC Coupled to Accurate Mass AxION 2 TOF Mass Spectrometer

Dienes Derivatization MaxSpec Kit

Supporting Information for Publication - page S-1. Comparative analysis of sample preparation methods to handle the complexity of

LC-MS/MS quantitative analysis of Polyunsaturated Omega 3, 6,7 and 9 Fatty Acids in Serum for

Reduced Ion Suppression and Improved LC/MS Sensitivity with Agilent Bond Elut Plexa

Author. Introduction. Small Molecule Pharmaceuticals & Generics

Detection, Confirmation, and Quantification of Chloramphenicol in Honey, Shrimp and Chicken Using the Agilent 6410 LC/MS Triple Quadrupole

Sample Concentration and Analysis of Human Hormones in Drinking Water

Analysis of Pesticides (II) Metribuzin & their metabolites in Rice Jun Yonekubo, Nihon Waters, JAPAN

Mass Spectrometry based metabolomics

LC/MS/MS SOLUTIONS FOR LIPIDOMICS. Biomarker and Omics Solutions FOR DISCOVERY AND TARGETED LIPIDOMICS

Analysis of HMF by HPLC

Sample Preparation is Key

Comprehensive Study of SLE as a Sample. Preparation Tool for Bioanalysis

Analysis of Trace Organic Contaminants in Water by LC-MS/MS. Tarun Anumol Agilent Environmental Workshop March 18 th, 2014

Noora Perkola Finnish Environment Institute. Nordic MS Symposium November 9, 2011, Båstad, Sweden

Characterization of an Unknown Compound Using the LTQ Orbitrap

Analysis of FAMEs Using Cold EI GC/MS for Enhanced Molecular Ion Selectivity

Detection of Low Level of Chloramphenicol in Milk and Honey with MIP SPE and LC-MS-MS

SUPPLEMENTARY DATA. Materials and Methods

Dr. Erin E. Chambers Waters Corporation. Presented by Dr. Diego Rodriguez Cabaleiro Waters Europe Waters Corporation 1

Iron depletion enhances production of antimicrobials by Pseudomonas

PHOTOCATALYTIC DECONTAMINATION OF CHLORANTRANILIPROLE RESIDUES IN WATER USING ZnO NANOPARTICLES. DR. A. RAMESH, Ph.D, D.Sc.,

Extraction of Aflatoxin M1 From Infant Formula Using ISOLUTE Myco SPE Columns prior to LC-MS/MS Analysis

Phospholipid characterization by a TQ-MS data based identification scheme

The Comparison of High Resolution MS with Triple Quadrupole MS for the Analysis of Oligonucleotides

Department of Chemistry & Nutrition and Food Technology, An-Najah National University, P.O. Box 7, Nablus, Palestine; 2

Edgar Naegele. Abstract

Simple Cancer Screening Based on Urinary Metabolite Analysis

LC/MS Method for Comprehensive Analysis of Plasma Lipids

Extraction of Multiple Mycotoxins From Nuts Using ISOLUTE Myco prior to LC-MS/MS Analysis

Supplementary Information. Effects of Perfluorooctanoic Acid on Metabolic Profiles in Brain and Liver of Mouse by a

Development of a Bioanalytical Method for Quantification of Amyloid Beta Peptides in Cerebrospinal Fluid

Identification and Quantitation of Microcystins by Targeted Full-Scan LC-MS/MS

MASS SPECTROMETRY BASED METABOLOMICS. Pavel Aronov. ABRF2010 Metabolomics Research Group March 21, 2010

Glycerolipid Analysis. LC/MS/MS Analytical Services

The Development of LC/MS Methods for Determination of Polar Drugs of Abuse in Biological Samples

application Natural Food Colorants Analysis of Natural Food Colorants by Electrospray and Atmospheric Pressure Chemical Ionization LC/MS

Fatty Acid Mass Spectrometry Protocol Updated 10/11/2007 By Daren Stephens

Determination of Pharmaceutical Residues in Bovine Milk via LC MS/MS Following Solid Phase Extraction

LOCALISATION, IDENTIFICATION AND SEPARATION OF MOLECULES. Gilles Frache Materials Characterization Day October 14 th 2016

Development and validation of a screening method for drug residues in fish, shrimp and eel using LC-HRMS

Pharmaceuticals in Michigan Waters

Profiling Analysis of Polysulfide Silane Coupling Agent

Automated Sample Preparation for FAME Analysis in Edible Oils Using an Agilent 7696A Sample Prep WorkBench

Automated Purification and Analytical Reinjection of a Small Molecule Drug, Probenecid, on a Gilson LC/MS Dual Function System

CHAPTER-6 IDENTIFICATION, AND CHARACTERISATION OF DEGRADATION IMPURITY IN VALSARTAN TABLETS

Million B. Woudneh, M. Coreen Hamilton, Jonathan P. Benskin, Guanghui Wang, John R. Cosgrove SETAC, Nashville November 2013

CONTENT. i iv ix. SVKM s NMIMS, School of Pharmacy and Technology Management

New Mass Spectrometry Tools to Transform Metabolomics and Lipidomics

A RAPID AND SENSITIVE ANALYSIS METHOD OF SUDAN RED I, II, III & IV IN TOMATO SAUCE USING ULTRA PERFORMANCE LC MS/MS

Ke He 1, Anne Timm 2, and Lee Blaney 1. University of Maryland Baltimore County. US Department of Agriculture Forest Service

What You Can t See Can Hurt You. How MS/MS Specificity Can Bite Your Backside

Extraction of Multiple Mycotoxins From Grain Using ISOLUTE Myco prior to LC-MS/MS Analysis

Pantothenic Acid. Shang-Jing Pan, Ph.D. Abbott Nutrition Columbus, Ohio, USA

Carnitine / Acylcarnitines Dried Blood Spots LC-MS/MS Analysis Kit User Manual

Choosing the metabolomics platform

Profiling Flavonoid Isomers in Highly Complex Citrus Juice Samples Using UPLC Ion Mobility Time-of-Flight Mass Spectrometry

Simultaneous Determination of Prescription and Designer Benzodiazepines in Urine and Blood by SPE and LC-MS/MS

A Novel Solution for Vitamin K₁ and K₂ Analysis in Human Plasma by LC-MS/MS

Metabolite identification in metabolomics: Database and interpretation of MSMS spectra

Performance of an ultra low elution volume 96-well plate

Interested in conducting your own webinar?

Author. Introduction. Abstract

DETECTION OF DICLAZURIL, POULTRY FEED ADDITIVE, BY LCMS

Neosolaniol. [Methods listed in the Feed Analysis Standards]

Shotgun Proteomics MS/MS. Protein Mixture. proteolysis. Peptide Mixture. Time. Abundance. Abundance. m/z. Abundance. m/z 2. Abundance.

Analysis of Limonin in Citrus Juice Using QuEChERS and LC-MS/MS

Low-level environmental phthalate exposure associates with urine metabolome. alteration in a Chinese male cohort

Comparison of Modern LC- MS/MS Techniques for Analysis of TOrCs in Water. Tarun Anumol, Shane Snyder NEMC 2014

Discovery Metabolomics - Quantitative Profiling of the Metabolome using TripleTOF Technology

Authors. Abstract. Introduction. Environmental

Application of a new capillary HPLC- ICP-MS interface to the identification of selenium-containing proteins in selenized yeast

Quantification of labile and stable non-polar arsenolipids in commercial fish meals and edible seaweed samples

William Wikoff : UC Davis (Committee chair) Pavel Aronov: Stanford University. John Asara: Harvard University. Vladimir Shulaev: University of Texas

Supporting Information

For personal use only. Please do not reuse or reproduce

Determination of Tetracyclines in Chicken by Solid-Phase Extraction and High-Performance Liquid Chromatography

LC Application Note.

Key Words: Brassica oleraceae, glucosinolate, liquid chromatography mass spectrometry, FNH-I-003

A UPLC/MS Approach for the Diagnosis of Inborn Errors of Metabolism

Chromatography Vacuum Ultraviolet Spectroscopy

Enhanced LC-MS Sensitivity of Vitamin D Assay by Selection of Appropriate Mobile Phase

SCREENING OF NEW PSYCHOACTIVE SUBSTANCES IN URINE SAMPLES BY HIGH RESOLUTION MASS SPECTROMETRY

Impurity Identification using a Quadrupole - Time of Flight Mass Spectrometer QTOF

Designer Fentanyls Drugs that kill and how to detect them. Cyclopropylfentanyl

Mass-Spectrometric Analysis of Lipids (Lipidomics)

CHARACTERIZATION AND DETECTION OF OLIVE OIL ADULTERATIONS USING CHEMOMETRICS

Application of LC/Electrospray Ion Trap Mass Spectrometry for Identification and Quantification of Pesticides in Complex Matrices

Determination of macrolide antibiotics, their intermediates and transformation products in solid environmental matrices

Target Compounds. Removal of EDCs and PPCPs by Oxidative Disinfection. Iopromide 514 Å 3. Erythromycin 710 Å 3. Acetaminophen 138 Å 3

Transcription:

Diana Álvarez Muñoz, Albert Serra Compte, Natàlia Corcoll, Belinda Huerta, Sara Rodríguez Mozaz, Sergi Sabater, Damià Barceló.

INTRODUCTION MATERIAL AND METHODS Experimental Analytical determination Signal processing and multivariate analysis RESULTS AND DISCUSSION Metabolites identification Biofilm response to environmental stressors CONCLUSIONS ACKNOWLEDGEMENTS

INTRODUCTION Drought Pollution Landfill Animal waste Aquaculture Hospital waste Industrial domestic waste Pharmaceuticals mixtures Chronic exposure

INTRODUCTION Biofilm Primary producers Biogeochemical cycle of organic and inorganic matter Sensitive to river changes Have a rapid interaction with dissolved substances Short life cycle Bioaccumulation capacity BIOMARKERS OF EXPOSURE DISRUPTED METABOLIC PATHWAYS

GOALS 1.To identify biofilm biomarkers of drought stress and pharmaceutical exposure. 2.To elucidate metabolic pathways affected due to a dry period and/or pharmaceutical exposure. 3.To evaluate if the effects of a dry period on the metabolome of biofilm was influenced for the co occurrence of pharmaceutical exposure.

MATERIAL AND METHODS Fluvial mesocosm Experimental Treatments: 1. Control (C) 2. Pharmaceutical exposure (P) Compound Therapeutic family Nominal Concentration (ng/l) Ibuprofen Anti inflammatory 404 Diclofenac Anti inflammatory 366 Carbamazepine Psychiatric drug 124 Sulfamethoxazole Antibiotic 699 Erithromycin Antibiotic 169 Metoprolol β Blocker 1845 Atenolol β Blocker 117 Gemfibrozil Lipid regulator 140 Hydrochlorothiazide Diuretic 1135 Total duration of the experiment 42 d 21 d colonization 7 d drought 14 d flow rewetting 3. Dry exposure (7 days) (D) 4. Dry and pharmaceutical exposure (D+P)

MATERIAL AND METHODS Analytical determination Samples were collected at the end of the experiment lyophilized and grounded Pressurized liquid extraction (ASE 350): ACN:citric buffer (1:1) Tª 60º C, 1500 psi, 3 static cycles of 5 min each Samples were dry down and re dissolve in 100 ml of water prior solid phase extraction (SPE) on OASIS HLB cartridges The eluates were evaporated and reconstituted in 1 ml of methanol, 10 µl ISTDs mix were also added. HPLC HRMS (LC LTQ Orbitrap Velos) Equipped with electrospray ionization operating both in positive and negative mode.

MATERIAL AND METHODS Signal processing and multivariate analysis Mass spectra: 100 700 m/z, deconvoluted and aligned using Sieve software. The markers were exported to R software for multivariate analysis. Clear separation between the biofilm exposed and not exposed to drought (D) Slight separation between control (C) group and biofilm exposed only to pharmaceuticals (P) Not clear separation between D and drought + pharmaceuticals (D+P) Identification of the markers: Accurate mass Elemental composition. Biochemical data bases Match up MS/MS response. Confirmation by STDs. Fig 1.Principal component analysis (PCA) of significant metabolites of biofilm exposed to the treatments

RESULTS AND DISCUSSION Metabolites identification Table 1.Tentative identification of markers in biofilm after treatments by using LC LTQ Orbitrap (ESI+ and ESI ). M/z value of marker ion RT (min) ESI 251.2003 5.29 + 279.2319 5.58 + 297.2424 5.85 + 191.0193 0.71 187.0975 3.73 269.2119 5.15 275.2012 5.76 255.2323 6.12 339.3264 6.75 367.3575 6.94 409.2353 9.62 253.2170 5.93 Putative experimental molecular formula of ion Theoretical mass METABOLIC PATHWAYS Error (ppm) Putative Identity C 16 H 27 O 2 [M+H] + 251.2011 3.2 LPA (16:3) C 18 H 31 O 2 [M+H] + 279.2324 1.8 alfa linolenic acid C 18 H 33 O 3 [M+H] + 297.2429 1.7 A vernolate C 6 H 7 O 7 [M H] 191.0192 0.5 Citrate C 9 H 15 O 4 [M H] 187.0970 2.7 Azelaic acid C 16 H 29 O 3 [M H] 269.2117 0.7 16 Oxohexadecanoic acid C 18 H 27 O 2 [M H] 275.2011 0.3 Stearidonic acid C 16 H 31 O 2 [M H] 255.2324 0.4 Palmitic acid C 22 H 43 O 2 [M H] 339.3263 0.3 Behenic acid C 24 H 47 O 2 [M H] 367.3576 0.3 Lignoceric acid C 19 H 38 O 7 P [M H] 409.2355 0.4 LPA(0:0/16:0) C 16 H 29 O 2 [M H] 253.2168 0.8 Palmitoleic acid

RESULTS AND DISCUSSION Metabolites identification Fragmentation pattern of Lysophosphatidic acid (LPA (0:0/16:0). Fig.2. A) Total ion chromatogram from biofilm sample exposed to pharmaceuticals, B) Mass spectrum of this compound at 30 v CID.

RESULTS AND DISCUSSION Biofilm response to environmental stressors Table 2. Significant variation of markers levels (p<0.05) in biofilm after each treatment compared to the control group. It is represented as an increase ( ) or decrease ( ).

RESULTS AND DISCUSSION Biofilm response to environmental stressors: Drought Table 3. metabolite type and response to a dry period Lipids were the most affected metabolites. Both saturated and unsaturated fatty acids increased after a dry period: changes in membrane fluidity, increase of energy reservoirs and a growth phase of microorganisms after drought. The increase in carboxilic acids: signaling functions. Oxohexadecanoic acid it is involved in unsaturated fatty acids biosynthesis.

RESULTS AND DISCUSSION Biofilm response to environmental stressors: pharmaceuticals Table 3. metabolite type and response to a pharmaceutical exposure Lipids were the most affected metabolites. Saturated fatty acids decreased after pharmaceutical exposure: higher demand and consume of energy. The increase of unsaturated fatty acids: conversion of saturated into unsaturated by the organism. Glycerophospholipid: baseline toxicity of pharmaceutical and alteration of the membrane structure.

CONCLUSSIONS LPA (0:0/16:0) and palmitic acid have been proposed as specific biomarkers of pharmaceutical exposure in biofilm. In the case of drought: palmitoleic, LPA (16:3), alpha linoleic, stearidonic, 16 Oxohexadecanoic, azelaic acids and citrate have been pointed out. Behenic and lignoceric acids have been also proposed but as common biomarkers with different observed effect. The biosynthesis of fatty acids is the main endogenous metabolic pathway disrupted by both stressors but other biological functions can also be altered: membrane fluidity, signaling, energy reservoirs. When biofilm was simultaneously exposed to drought and pharmaceuticals the stressor that produced a higher alteration on the biofilm metabolome was the drought, although a slight alteration due to the co ocurrence of pharmaceuticals can not be discarded.

Acknowledgements Thanks to all the co authors specially to Albert Serra and Natalia Corcoll. This project was supported by the Scarce Consolider Ingenio 2010 (CSD2009 00065) Assessing and Predicting Effects On Water Quantity and Quality In Iberian Rivers Caused By Global Change (2009 2014) and the Spanish ministry of economy and competitiveness. To all of you for your attention. Thank you!